Impact of number of lifetime antiseizure medications on 12-month effectiveness, quality of life and tolerability outcomes of adjunctive brivaracetam in patients with focal seizures: Post-hoc analysis of a real-world European study

被引：0
|
作者：
Leach, J. [1 ]
Kelemen, A. [2 ]
Doherty, C. [3 ,4 ]
Schulz, A. -L. [5 ]
Brock, F. [6 ]
Leunikava, I.
Bourikas, D. [7 ]
Steinhoff, B. [8 ]
机构：
[1] Univ Glasgow, Sch Med, Glasgow, Lanark, Scotland
[2] Natl Inst Clin Neurosci, Budapest, Hungary
[3] Trinity Coll Dublin, Dublin, Ireland
[4] RCSI, FutureNeuro, SFI Res Ctr, Dublin, Ireland
[5] UCB Pharma, Monheim, Germany
[6] UCB Pharma, Slough, Berks, England
[7] UCB Pharma, Alimos, Greece
[8] Kork Epilepsy Ctr, Kehl, Germany
来源：
EPILEPSIA | 2022年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
309
引用
收藏
页码：64 / 64
页数：1
相关论文
共 31 条
  • [21] Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East
    Achiron, Anat
    Aref, Hany
    Inshasi, Jihad
    Harb, Mohamad
    Alroughani, Raed
    Bijarnia, Mahendra
    Cooke, Kathryn
    Yuksel, Ozgur
    BMC NEUROLOGY, 2017, 17
  • [22] Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East
    Anat Achiron
    Hany Aref
    Jihad Inshasi
    Mohamad Harb
    Raed Alroughani
    Mahendra Bijarnia
    Kathryn Cooke
    Ozgur Yuksel
    BMC Neurology, 17
  • [23] Real-world effectiveness and safety of damoctocog alfa pegol in patients with haemophilia A and a history of factor VIII inhibitors: A post-hoc analysis of the ongoing HEM-POWR study
    Reding, Mark
    Alvarez-Roman, Maria Teresa
    Castaman, Giancarlo
    Janbain, Maissaa
    Matsushita, Tadashi
    Meijer, Karina
    Schmidt, Kathrin
    Oldenburg, Johannes
    HAEMOPHILIA, 2024, 30 : 34 - 35
  • [24] Mirabegron improves quality-of-life, treatment satisfaction, and persistence in patients with overactive bladder: a multi-center, non-interventional, real-world, 12-month study
    Freeman, Robert
    Foley, Steve
    Rosa Arias, Jose
    Vicente, Eduardo
    Grill, Robert
    Kachlirova, Zuzana
    Stari, Anny
    Huang, Moses
    Choudhury, Nurul
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (05) : 785 - 793
  • [25] Importance of continuous treatment with intravitreal aflibercept injections in patients with neovascular age-related macular degeneration-12-month post hoc analysis of the PERSEUS real-world evidence study
    Wachtlin, Joachim
    Eter, Nicole
    Hasanbasic, Zoran
    Keramas, Georgios
    Rech, Christine
    Sachs, Helmut
    Schilling, Harald
    Wiedemann, Peter
    Framme, Carsten
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2021, 259 (03) : 601 - 611
  • [26] Safety and effectiveness of tofogliflozin in Japanese patients with type 2 diabetes mellitus in real-world practice: Results of 12-month interim analysis of a long-term post-marketing surveillance study (J-STEP/LT)
    Utsunomiya, Kazunori
    Senda, Masayuki
    Kakiuchi, Seigo
    Kameda, Hiroyuki
    Tamura, Masahiro
    Kurihara, Yuji
    Gunji, Ryoji
    Fujii, Shoko
    Kaku, Kohei
    JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (01) : 132 - 141
  • [27] Effectiveness outcomes and health related quality of life impact of disease progression in patients with advanced nonsquamous NSCLC treated in real-world community oncology settings: results from a prospective medical record registry study
    Mark S. Walker
    William Wong
    Arliene Ravelo
    Paul J. E. Miller
    Lee S. Schwartzberg
    Health and Quality of Life Outcomes, 15
  • [28] Effectiveness outcomes and health related quality of life impact of disease progression in patients with advanced nonsquamous NSCLC treated in real-world community oncology settings: results from a prospective medical record registry study
    Walker, Mark S.
    Wong, William
    Ravelo, Arliene
    Miller, Paul J. E.
    Schwartzberg, Lee S.
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2017, 15
  • [29] Effectiveness, safety, and health-related quality of life outcomes in patients with hemophilia A receiving antihemophilic factor (recombinant) in a real-world setting: results of a 6-year interim analysis of the AHEAD International study
    Oldenburg, Johannes
    Ozelo, Margareth C.
    Klamroth, Robert
    Guillet, Benoit
    Khair, Kate
    Tsakiris, Dimitrios A.
    Botha, Jaco
    Fernandez, Alejandro
    Tang, Leilei
    Santagostino, Elena
    HAEMOPHILIA, 2020, 26 : 95 - 96
  • [30] Real-World Effectiveness and Safety of Cladribine Tablets in Patients with Relapsing MS after Suboptimal Response to Prior Oral or Infusion Disease-Modifying Therapy: 12-Month Interim Analysis from the US-Based Phase 4 MASTER-2 Study
    Crayton, Heidi
    Valenzuela, Reuben
    Katz, Joshua
    Aldridge, Julie
    Evans, Emily
    Chandler, Angela
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 381 - 381
1234